Are Psychotropic Medications Effective in Chronic Pain Management in Children and Adolescents? A Meta-Analysis of Randomized Control Trials

Overview

Journal J Pain Res

Publisher Dove Medical Press

Date 2021 Jul 1

PMID 34194243

Citations 5

Authors

Taranjeet Jolly

Zeeshan Mansuri

Chintan Trivedi

Mahwish Adnan

Steven P Cohen

To-Nhu Vu

Affiliations

Soon will be listed here.

Abstract

Objective: Data defining and subsequently guiding the use of psychotropic medications in children and adolescents is sparse. We conducted a meta-analysis of randomized control trials to examine the effectiveness of psychotropic medications in children and adolescents with chronic pain.

Methods: We conducted a comprehensive literature search from published studies, and annual scientific sessions of psychiatry conferences. We identified double-blind, randomized control trials (RCTs) in which psychotropic medications were compared to placebo. Data was collected for the total number of patients, baseline characteristics, and changes in pain score. Meta-analysis was performed using a random effect model evaluating average change in pain score and the number of patients with a reduction in pain score for both groups. Pooled data are expressed as standardized mean differences (SMD) and odds ratios (OR) with 95% confidence intervals (CI).

Results: We found 5 studies that included amitriptyline (n=2), citalopram (n=1), buspirone (n=1) and duloxetine (n=1). In the pooled analysis for the difference in the average change in pain score, 4 RCTs with 395 patients were included. After 12-13 weeks of therapy, reductions in pain score were significantly greater in the psychotropic drug group as compared to placebo (SMD: -0.77, 95% CI -1.54, 0.0001, p= 0.05). For the analysis on the number of patients with a reduction in pain, data were available for 445 patients (224-medication group, 221-placebo group). More patients in the psychotropic drug group experienced a meaningful reduction in pain score at 12-13 weeks of therapy compared to placebo (OR 1.66, 95% CI 1.08-2.54, p= 0.02).

Conclusion: The results of this meta-analysis demonstrate significant analgesic efficacy of psychotropic medications in the management of children with chronic pain. This review is limited by the small number of studies included for analysis. There is a pressing need for more robust clinical trials to further investigate these promising findings.

Citing Articles

Should cognitive behavioral therapy for insomnia be considered for preventing and managing chronic pain?.

Klyne D, Smith S, Hall M Sleep. 2024; 47(10).

PMID: 39093687 PMC: 11467058. DOI: 10.1093/sleep/zsae177.

Demographics, Diagnoses, Drugs, and Adjuvants in Patients on Chronic Opioid Therapy vs. Intermittent Use in a Tertiary Pediatric Chronic Pain Clinic.

Tolley J, Michel M, Sarmiento E Children (Basel). 2023; 10(1).

PMID: 36670588 PMC: 9856724. DOI: 10.3390/children10010037.

Mechanism-Based Pharmacological Treatment for Chronic Non-cancer Pain in Adolescents: Current Approaches and Future Directions.

Bruneau A, Carrie S, Moscaritolo L, Ingelmo P Paediatr Drugs. 2022; 24(6):573-583.

PMID: 36053398 DOI: 10.1007/s40272-022-00534-x.

Antidepressant in the Treatment of Chronic Pain: A Case Report of Adult-Onset Still's Disease.

Jain A, Bodicherla K, Vanaparthy R Cureus. 2022; 13(12):e20180.

PMID: 35004004 PMC: 8723779. DOI: 10.7759/cureus.20180.

Chronic Pediatric Pain and Mental Illness During the COVID-19 Era: A Case Series From Inpatient Child Psychiatry Unit.

Jain A, Gee S, Malayala S, Laboe C Cureus. 2022; 13(11):e20032.

PMID: 34987917 PMC: 8716159. DOI: 10.7759/cureus.20032.

References

Patetsos E, Horjales-Araujo E . Treating Chronic Pain with SSRIs: What Do We Know?. Pain Res Manag. 2016; 2016:2020915. PMC: 4947493. DOI: 10.1155/2016/2020915. View

Roth-Isigkeit A, Thyen U, Raspe H, Stoven H, Schmucker P . Reports of pain among German children and adolescents: an epidemiological study. Acta Paediatr. 2004; 93(2):258-63. View

Upadhyaya H, Arnold L, Alaka K, Qiao M, Williams D, Mehta R . Efficacy and safety of duloxetine versus placebo in adolescents with juvenile fibromyalgia: results from a randomized controlled trial. Pediatr Rheumatol Online J. 2019; 17(1):27. PMC: 6540374. DOI: 10.1186/s12969-019-0325-6. View

Walitt B, Urrutia G, Nishishinya M, Cantrell S, Hauser W . Selective serotonin reuptake inhibitors for fibromyalgia syndrome. Cochrane Database Syst Rev. 2015; (6):CD011735. PMC: 4755337. DOI: 10.1002/14651858.CD011735. View

Obata H . Analgesic Mechanisms of Antidepressants for Neuropathic Pain. Int J Mol Sci. 2017; 18(11). PMC: 5713449. DOI: 10.3390/ijms18112483. View

Kashikar-Zuck S, Goldschneider K, Powers S, Vaught M, HERSHEY A . Depression and functional disability in chronic pediatric pain. Clin J Pain. 2002; 17(4):341-9. DOI: 10.1097/00002508-200112000-00009. View

Sleed M, Eccleston C, Beecham J, Knapp M, Jordan A . The economic impact of chronic pain in adolescence: methodological considerations and a preliminary costs-of-illness study. Pain. 2005; 119(1-3):183-190. DOI: 10.1016/j.pain.2005.09.028. View

Goodman J, McGrath P . The epidemiology of pain in children and adolescents: a review. Pain. 1991; 46(3):247-264. DOI: 10.1016/0304-3959(91)90108-A. View

Higgins J, Altman D, Gotzsche P, Juni P, Moher D, Oxman A . The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ. 2011; 343:d5928. PMC: 3196245. DOI: 10.1136/bmj.d5928. View

10.

Jordan A, Eccleston C, Osborn M . Being a parent of the adolescent with complex chronic pain: an interpretative phenomenological analysis. Eur J Pain. 2006; 11(1):49-56. DOI: 10.1016/j.ejpain.2005.12.012. View

11.

Eccleston C, Crombez G, Scotford A, Clinch J, Connell H . Adolescent chronic pain: patterns and predictors of emotional distress in adolescents with chronic pain and their parents. Pain. 2004; 108(3):221-229. DOI: 10.1016/j.pain.2003.11.008. View

12.

Finnerup N, Attal N, Haroutounian S, McNicol E, Baron R, Dworkin R . Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis. Lancet Neurol. 2015; 14(2):162-73. PMC: 4493167. DOI: 10.1016/S1474-4422(14)70251-0. View

13.

Saps M, Youssef N, Miranda A, Nurko S, Hyman P, Cocjin J . Multicenter, randomized, placebo-controlled trial of amitriptyline in children with functional gastrointestinal disorders. Gastroenterology. 2009; 137(4):1261-9. PMC: 2827243. DOI: 10.1053/j.gastro.2009.06.060. View

14.

Roohafza H, Pourmoghaddas Z, Saneian H, Gholamrezaei A . Citalopram for pediatric functional abdominal pain: a randomized, placebo-controlled trial. Neurogastroenterol Motil. 2014; 26(11):1642-50. DOI: 10.1111/nmo.12444. View

15.

Hjermstad M, Fayers P, Haugen D, Caraceni A, Hanks G, Loge J . Studies comparing Numerical Rating Scales, Verbal Rating Scales, and Visual Analogue Scales for assessment of pain intensity in adults: a systematic literature review. J Pain Symptom Manage. 2011; 41(6):1073-93. DOI: 10.1016/j.jpainsymman.2010.08.016. View

16.

Bahar R, Collins B, Steinmetz B, Ament M . Double-blind placebo-controlled trial of amitriptyline for the treatment of irritable bowel syndrome in adolescents. J Pediatr. 2008; 152(5):685-9. DOI: 10.1016/j.jpeds.2007.10.012. View

17.

Merlijn V, Hunfeld J, van der Wouden J, Hazebroek-Kampschreur A, Koes B, Passchier J . Psychosocial factors associated with chronic pain in adolescents. Pain. 2003; 101(1-2):33-43. DOI: 10.1016/s0304-3959(02)00289-0. View

18.

Perquin C, Hazebroek-Kampschreur A, Hunfeld J, Bohnen A, van Suijlekom-Smit L, Passchier J . Pain in children and adolescents: a common experience. Pain. 2000; 87(1):51-58. DOI: 10.1016/S0304-3959(00)00269-4. View

19.

Lyubashina O, Busygina I, Panteleev S, Nozdrachev A . Antinociceptive effect of the agonist of 5-HT1A receptors buspirone in the model of abdominal pain in dogs. Dokl Biol Sci. 2017; 473(1):46-49. DOI: 10.1134/S0012496617020119. View

20.

Jackson J, Mancuso J, Nickoloff S, Bernstein R, Kay C . Tricyclic and Tetracyclic Antidepressants for the Prevention of Frequent Episodic or Chronic Tension-Type Headache in Adults: A Systematic Review and Meta-Analysis. J Gen Intern Med. 2017; 32(12):1351-1358. PMC: 5698213. DOI: 10.1007/s11606-017-4121-z. View